Novavax Inc (NVAX)
4.07
+0.12
(+3.04%)
USD |
NASDAQ |
Apr 26, 16:00
4.07
0.00 (0.00%)
After-Hours: 16:36
Novavax Cash from Investing (TTM): -58.81M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -58.81M |
September 30, 2023 | -71.79M |
June 30, 2023 | -82.92M |
March 31, 2023 | -99.72M |
December 31, 2022 | -92.98M |
September 30, 2022 | -87.28M |
June 30, 2022 | -69.96M |
March 31, 2022 | -58.28M |
December 31, 2021 | 100.15M |
September 30, 2021 | 85.40M |
June 30, 2021 | -3.124M |
March 31, 2021 | -178.44M |
December 31, 2020 | -377.78M |
September 30, 2020 | -346.87M |
June 30, 2020 | -228.19M |
March 31, 2020 | -37.95M |
December 31, 2019 | 38.49M |
September 30, 2019 | 87.03M |
June 30, 2019 | 77.05M |
March 31, 2019 | 26.72M |
December 31, 2018 | 28.60M |
September 30, 2018 | -2.959M |
June 30, 2018 | 31.00M |
March 31, 2018 | 81.84M |
December 31, 2017 | 35.97M |
Date | Value |
---|---|
September 30, 2017 | 105.11M |
June 30, 2017 | 155.72M |
March 31, 2017 | 172.17M |
December 31, 2016 | 28.02M |
September 30, 2016 | -48.33M |
June 30, 2016 | -150.11M |
March 31, 2016 | -208.50M |
December 31, 2015 | -21.27M |
September 30, 2015 | -13.48M |
June 30, 2015 | -58.37M |
March 31, 2015 | -121.75M |
December 31, 2014 | -129.83M |
September 30, 2014 | -138.02M |
June 30, 2014 | -68.51M |
March 31, 2014 | 31.07M |
December 31, 2013 | 16.39M |
September 30, 2013 | -9.884M |
June 30, 2013 | -32.64M |
March 31, 2013 | -33.97M |
December 31, 2012 | -32.26M |
September 30, 2012 | -14.34M |
June 30, 2012 | -3.37M |
March 31, 2012 | 7.288M |
December 31, 2011 | 18.54M |
September 30, 2011 | 14.44M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-377.78M
Minimum
Dec 2020
100.15M
Maximum
Dec 2021
-74.00M
Average
-69.96M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
Pfizer Inc | -32.28B |
Moderna Inc | 4.206B |
Agilent Technologies Inc | -301.00M |
Lexicon Pharmaceuticals Inc | -49.94M |
Vaxart Inc | 43.95M |